MARZARO, GIOVANNI
 Distribuzione geografica
Continente #
EU - Europa 1.252
AS - Asia 1.135
NA - Nord America 799
SA - Sud America 294
AF - Africa 67
OC - Oceania 1
Totale 3.548
Nazione #
RU - Federazione Russa 871
US - Stati Uniti d'America 767
SG - Singapore 549
BR - Brasile 249
HK - Hong Kong 215
GB - Regno Unito 127
CN - Cina 111
VN - Vietnam 109
KR - Corea 68
IT - Italia 65
DE - Germania 56
BJ - Benin 48
AT - Austria 34
NL - Olanda 24
BD - Bangladesh 18
FI - Finlandia 17
MX - Messico 17
AR - Argentina 16
ID - Indonesia 14
IN - India 13
CA - Canada 12
TR - Turchia 11
EC - Ecuador 10
JP - Giappone 9
PL - Polonia 9
SE - Svezia 9
IE - Irlanda 8
ZA - Sudafrica 8
ES - Italia 7
FR - Francia 7
CO - Colombia 5
UA - Ucraina 5
IQ - Iraq 4
LT - Lituania 4
PY - Paraguay 4
KE - Kenya 3
MA - Marocco 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
IL - Israele 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GR - Grecia 1
HN - Honduras 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LV - Lettonia 1
MG - Madagascar 1
NO - Norvegia 1
PA - Panama 1
PS - Palestinian Territory 1
RO - Romania 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
Totale 3.548
Città #
Moscow 302
Hong Kong 213
Singapore 206
Dallas 191
Ashburn 128
London 54
Cotonou 48
Los Angeles 47
Beijing 40
Redondo Beach 37
Ho Chi Minh City 34
The Dalles 33
São Paulo 24
Nuremberg 22
Buffalo 20
New York 19
Chandler 18
Verona 18
Vienna 18
Hanoi 17
Munich 14
Southend 13
Brooklyn 12
Jacksonville 12
Amsterdam 11
Mexico City 11
Chicago 9
Jakarta 9
Dublin 8
Haiphong 8
Istanbul 8
Johannesburg 8
Lappeenranta 7
Poplar 7
San Francisco 7
Turku 7
Warsaw 7
Biên Hòa 6
Boston 6
Dong Ket 6
Orem 6
Phoenix 6
Uberlândia 6
Atlanta 5
Belo Horizonte 5
Brasília 5
Council Bluffs 5
Manchester 5
Ribeirão Preto 5
Rio de Janeiro 5
Santa Clara 5
Tianjin 5
Columbus 4
Goiânia 4
Guayaquil 4
Montreal 4
Rome 4
Seattle 4
Toronto 4
Wilmington 4
Agadir 3
Ann Arbor 3
Baghdad 3
Bologna 3
Denver 3
Des Moines 3
Fortaleza 3
Frankfurt am Main 3
Guangzhou 3
Göttingen 3
Helsinki 3
Hải Dương 3
Lawrence 3
Macaé 3
Meda 3
Milan 3
Padua 3
Porto Alegre 3
Princeton 3
Quito 3
Salvador 3
St Petersburg 3
Stockholm 3
Tokyo 3
Aracaju 2
Atibaia 2
Boardman 2
Bogotá 2
Campo Belo 2
Changsha 2
Charlotte 2
Chennai 2
Colombo 2
Curitiba 2
Falkenstein 2
Formosa 2
Guararema 2
Guarulhos 2
Ha Long 2
Haikou 2
Totale 1.864
Nome #
Differential Effects of Angelicin Analogues on NF-κB Activity and IL-8 Gene Expression in Cystic Fibrosis IB3-1 Cells 136
Molecular Mechanism of Action of Trimethylangelicin Derivatives as CFTR Modulators 106
Development of transdermal delivery systems for innovative clinical applications of cannabinoids 103
Design, synthesis and biological evaluation of novel trimethylangelicin analogues targeting nuclear factor kB (NF-kB) 89
A NEW PRODUCTION METHOD OF HIGH SPECIFIC ACTIVITY RADIONUCLIDES TOWARDS INNOVATIVE RADIOPHARMACEUTICALS: THE ISOLPHARM PROJECT 73
A Novel Aza-Derivative Inhibits agr Quorum Sensing Signaling and Synergizes Methicillin-Resistant Staphylococcus aureus to Clindamycin 72
Biological evaluation of psoralen derivatives as inhibitors of NF-kappa B/DNA interaction: molecular modeling, 3D-QSAR, EMSA assays and inhibition of IL-8 gene expression 72
Assessing the interaction between hemoglobin and the receptor binding domain of SARS-CoV-2 spike protein through MARTINI coarse-grained molecular dynamics 72
Biphenyl tricyclic quinazoline compounds 70
Aged garlic extract major constituent S-1-propenyl-l-cysteine inhibits proinflammatory mRNA expression in bronchial epithelial IB3-1 cells exposed to the BNT162b2 vaccine 69
A microwave improvement in the synthesis of the quinazoline scaffold 68
Improved Trimethylangelicin Analogs for Cystic Fibrosis: Design, Synthesis and Preliminary Screening 67
Deformable Vesicles with Edge Activators for the Transdermal Delivery of Non-Psychoactive Cannabinoids 67
Corrigendum to: Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib [Eur. J. Med. Chem. 172 (2019) 143?153] (European Journal of Medicinal Chemistry (2019) 172 (143?153), (S0223523419302983), (10.1016/j.ejmech.2019.03.064)) 66
Aged Garlic Extract (AGE) and Its Constituent S-Allyl-Cysteine (SAC) Inhibit the Expression of Pro-Inflammatory Genes Induced in Bronchial Epithelial IB3-1 Cells by Exposure to the SARS-CoV-2 Spike Protein and the BNT162b2 Vaccine 65
Corilagin induces high levels of apoptosis in the temozolomide-resistant T98G glioma cell line 62
A novel approach to quinazolin-4(3H)-one via quinazoline oxidation: an improved synthesis of 4-anilinoquinazolines 61
A new access to quinazolines from simple anilines 60
Biodistribution Assessment of a Novel 68Ga-Labeled Radiopharmaceutical in a Cancer Overexpressing CCK2R Mouse Model: Conventional and Radiomics Methods for Analysis 58
Design and Preclinical Evaluation of a Novel Prostate-Specific Membrane Antigen Radioligand Modified with a Transthyretin Binder 54
Development and Validation of Novel Z-360-Based Macromolecules for the Active Targeting of CCK2-R 54
A novel phenolic derivative inhibits AHL-dependent Quorum Sensing signaling in Pseudomonas aeruginosa 52
Benzoquinazoline derivatives as new agents affecting DNA processing 50
Potential applications of components of aged garlic extract in mitigating pro-inflammatory gene expression linked to human diseases (Review) 50
Synthesis and Biological Evaluation of Pyrazole–Pyrimidones as a New Class of Correctors of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) 50
Autogrid-based clustering of kinases: Selection of representative conformations for docking purposes 48
A novel convenient synthesis of benzoquinazolines 48
Qsar and 3d-qsar models in the field of tubulin inhibitors as anticancer agents 48
Synthesis and evaluation of tricyclic quinazoline derivatives as egfr inhibitors 46
Effects of analogues of 4,6,4'-trymethylangelicin on erythroid differentiation and NF-kB activity 45
Quinazoline derivatives as potential anticancer agents: A patent review (2007 - 2010) 44
Preliminary evaluation of the production of non-carrier added 111Ag as core of a therapeutic radiopharmaceutical in the framework of ISOLPHARM_Ag experiment 44
New topoisomerase inhibitors as proapoptotic agents 44
Quinazoline-based multi-tyrosine kinase inhibitors: Synthesis, modeling, antitumor and antiangiogenic properties 43
The moss Macromitrium richardii (Orthotrichaceae) with sporophyte and calyptra enclosed in Hymenaea resin from the Dominican Republic 43
Oleocanthalic acid improves MASH features via a NOX1-dependent mechanism 41
Discovery of selective, metabolically stable pyrazole-based FLT3 inhibitors for the treatment of acute myeloid leukemia 40
Structural and Functional Insights on an Uncharacterized Aγ-Globin-Gene Polymorphism Present in Four β0-Thalassemia Families with High Fetal Hemoglobin Levels 40
Tyrosine kinase inhibitor prodrug-loaded liposomes for controlled release at tumor microenvironment 39
Inhibitory effects of SARS-CoV-2 spike protein and BNT162b2 vaccine on erythropoietin-induced globin gene expression in erythroid precursor cells from patients with β-thalassemia 39
Development of a novel furocoumarin derivative inhibiting NF-κB dependent biological functions: Design, synthesis and biological effects 39
null 39
Psoralen derivatives as inhibitors of NF-κB/DNA interaction: Synthesis, molecular modeling, 3D-QSAR, and biological evaluation 39
Microwave-promoted mono-N-alkylation of aromatic amines in water: A new efficient and green method for an old and problematic reaction 38
Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting 38
The ISOLPHARM project: ISOL-based production of radionuclides for medical applications 37
Discovery of biarylaminoquinazolines as novel tubulin polymerization inhibitors 37
Early evaluation of copper radioisotope production at ISOLPHARM 36
SAM50, a side door to the mitochondria: The case of cytotoxic proteases 36
Targeting DNA Binding for NF-κB as an Anticancer Approach in Hepatocellular Carcinoma 36
Investigational drugs targeting cyclin-dependent kinases for the treatment of cancer: an update on recent findings (2013-2016) 35
Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors 35
New Vandetanib analogs: Fused tricyclic quinazolines with antiangiogenic potential 35
Targeting kinases with anilinopyrimidines: Discovery of N-phenyl-N'-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of class III receptor tyrosine kinase subfamily 35
Novel benzoquinoline derivatives via unpredicted condensation of ethyl propiolate and naphthylamines: Synthesis and topoisomerase inhibition activity 35
Dual Kinase Targeting in Leukemia 34
Proteolysis Targeting Chimeric Molecules: Tuning Molecular Strategies for a Clinically Sound Listening 34
Novel Methods for the Production of Radionuclides of Medical Interest With Accelerators 34
The importance of descriptor-based clusterization in QSAR models development: Tyrosine kinases inhibitors as a key study 34
Discovery of wtRET and V804MRET Inhibitors: From Hit to Lead 34
Surface plasmon resonance based analysis of the binding of LYAR protein to the rs368698783 (G\>A) polymorphic A?-globin gene sequences mutated in ?-thalassemia 34
Substituted quinazolinones as kinase inhibitors endowed with anti-fibrotic properties 33
Photobiological properties of 3-psoralenacetic acids 33
Preliminary Discovery of Small Molecule Inhibitors of Epidermal Growth Factor Receptor (EGFR) That Bind to the Extracellular Domain 33
Toward novel sulphur-containing derivatives of tetraazacyclododecane: Synthesis, acid-base properties, spectroscopic characterization, DFT calculations, and cadmium(ii) complex formation in aqueous solution 32
Psoralen derivatives as inhibitors of NF-κB/DNA interaction: the critical role of the furan ring 32
Lejeuneaceae (Marchantiophyta) from a species-rich taphocoenosis in Miocene Mexican amber, with a review of liverworts fossilised in amber 32
Exploring Epidermal Growth Factor Receptor (EGFR) inhibitor features: The role of fused dioxygenated rings on the quinazoline scaffold 31
Photochemical and photobiological studies on furoquinazolines as new psoralen analogs 31
The anti-SARS-CoV-2 BNT162b2 vaccine suppresses mithramycin-induced erythroid differentiation and expression of embryo-fetal globin genes in human erythroleukemia K562 cells 31
Pyrroloquinolinone-based dual topoisomerase I/II inhibitor 28
Third-generation CDK inhibitors: A review on the synthesis and binding modes of Palbociclib, Ribociclib and Abemaciclib 27
Effects of Sulforaphane on SARS‑CoV‑2 infection and NF‑κB dependent expression of genes involved in the COVID‑19 ‘cytokine storm’ 26
Psoralenquinones as a novel class of proteasome inhibitors: Design, synthesis and biological evaluation 26
Synthesis and antitumor activity of novel amsacrine analogs: The critical role of the acridine moiety in determining their biological activity 26
Multicomponent Assembly of the Kinesin Spindle Protein Inhibitor CPUYJ039 and Analogues as Antimitotic Agents 25
Structure-Based drug design and combinatorial chemistry in the search of antimitotic agents 24
Known triterpenes and their derivatives as scaffolds for the development of new therapeutic agents for cancer 24
Repurposing MK-8245 as a Quorum Sensing Inhibitor to Suppress Virulence and Potentiate Antibiotic Activity in Pseudomonas aeruginosa 13
Development of lisinopril radioconjugates for nuclear imaging of the angiotensin converting enzyme 4
Totale 3.663
Categoria #
all - tutte 12.335
article - articoli 11.709
book - libri 0
conference - conferenze 233
curatela - curatele 0
other - altro 205
patent - brevetti 188
selected - selezionate 0
volume - volumi 0
Totale 24.670


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 3 1 0 1 0 4 9
2021/202215 1 0 0 1 0 1 0 2 2 0 1 7
2022/202355 3 4 3 9 4 16 2 4 7 1 2 0
2023/202421 0 3 1 0 6 5 0 2 0 1 3 0
2024/20251.126 4 6 2 14 27 150 75 45 148 104 182 369
2025/20262.359 321 224 259 605 928 22 0 0 0 0 0 0
Totale 3.663